Thomas Schroeder

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells

Nimitha R. Mathew, Francis Baumgartner, Lukas M. Braun et al. · Nature Medicine · 2018 · 283 citations · Full text

Cell Therapy, Flt3-itd-mutant Leukemia Cells, Immunology +7

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

Richard F. Schlenk, Daniela Weber, Walter Fiedler et al. · Blood · 2018 · 283 citations · Full text

Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells

Stefanie Geyh, Simin Öz, R-P Cadeddu et al. · Leukemia · 2013 · 225 citations

Regenerative Medicine, Chromatin, Mds Results +10

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

Stephan Metzelder, Thomas Schroeder, Anemone Finck et al. · Leukemia · 2012 · 225 citations

Hematological Malignancy, Sustained Responses, Allergy +12

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

Thomas Schroeder, Akos Czibere, Uwe Platzbecker et al. · Leukemia · 2013 · 220 citations

Cell Therapy, Transplantation, Marrow Transplantation +7